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Abstract
Paracoccidioidomycosis is a mycotic disease caused by a dimorphic fungus, Paracoccidioides brasiliensis (Pb), that starts with
inhalation of the fungus; thus, lung cells such as DC are part of the first line of defense against this microorganism.
Migration of DC to the lymph nodes is the first step in initiating T cell responses. The mechanisms involved in resistance to
Pb infection are poorly understood, but it is likely that DC play a pivotal role in the induction of effector T cells that control
Pb infection. In this study, we showed that after Pb Infection, an important modification of lung DC receptor expression
occurred. We observed an increased expression of CCR7 and CD103 on lung DC after infection, as well as MHC-II. After Pb
infection, bone marrow-derived DC as well lung DC, migrate to lymph nodes. Migration of lung DC could represent an
important mechanism of pathogenesis during PCM infection. In resume our data showed that Pb induced DC migration.
Furthermore, we demonstrated that bone marrow-derived DC stimulated by Pb migrate to the lymph nodes and activate a T
helper (Th) response. To the best of our knowledge, this is the first reported data showing that Pb induces migration of DC
and activate a T helper (Th) response.
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Introduction
Paracoccidioidomycosis (PCM) is a mycotic disease caused by a
dimorphic fungus, Paracoccidioides brasiliensis (Pb), which initiates a
deep mycosis that primarily attacks lung tissue. PCM is the most
prevalent deep mycosis in Latin America. Epidemiological and
experimental evidence suggests that natural infection is initiated
after inhalation of the conidia produced by the mycelial form of the
fungus [1]. Clinical forms of PCM vary from a localized and benign
disease to a progressive and potentially lethal systemic infection [2].
The broad spectrum of clinical forms is a result of the influence of
several factors on disease severity including host response and
virulence of the infecting agent [3]. The acute or severe form of the
disease is associated with deficient cell immunity, high antibodies
(Abs) levels, and preferential secretion of type 2 cytokines [4].
Dendritic cells (DC) are antigen-presenting cells that act as
sentinels in peripheral tissues, constantly sampling the antigens in
their environment. Lung DC play a pivotal role in infections caused
by airborne pathogens such as Mycobacterium tuberculosis, Aspergillus
fumigatus and Cryptococcus neoformans [5][6][7][8]. The DC population
lining the lungs is key to the initiation of T cell responses after
pulmonary challenge [9]. DC remain quiescent until activated, at
which point they migrate to the draining lymph nodes (DLN) [10],
present antigen, and initiate T cell activation [11].
The mechanisms involved in resistance to Pb infection are
poorly understood, but it is likely that DC play a pivotal role in the
induction of effector T cells that control Pb infection. For example,
the production of IFN-c and IL-10, both effector T cell products,
appears to be involved in the resolution and dissemination of PCM
in both mice and humans [12][13].
Because DC are the most effective antigen presenting cells
(APC) for inducing cell-mediated immune responses, it is
important to investigate lung DC and their potential for lymph
node migration and immune response initiation. In this study, we
analyzed the role that DC played in modulating Pb infection. To
the best of our knowledge, this is the first reported data showing
that Pb induces migration of DC. Furthermore, we demonstrated
that bone marrow-derived DC stimulated by Pb migrate to the
lymph nodes and activate a T-cell response.
Methods
Ethics Statement
The protocol was approved by the Committee on the Ethics of
Animal Experiments of the University of Sao Paulo in 02/2009
(Permit Number: 154).
Animals
For this study, we used 8 to 12-week-old BALB/c female mice
obtained from the specific pathogen free facility of the University
of Sao Paulo and kept in the animal room, with constant
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19690temperature and humidity with cycle of dark/light, conformed to
institutional guidelines for animal care and welfare.
P. brasiliensis strains
The yeast form of the highly virulent P. brasiliensis strain 18 was
grown in Sabouraud-agar. The strain used was recovered from
animals before the experiments. A suspension of fungi was
prepered with sterile PBS and yeast cells were adjusted to 1610
5
cells in 50 ml, based on hemocytometer counts. Viability was
determined with Janus Green B vital dye (Merck) and was always
higher than 90%.
Mouse infection
Mice were challenged with an intratracheal inoculation of
1610
5 yeast cells of the virulent Pb strain 18. After 12 or 24 hrs,
the lungs and lymph nodes were removed prior to DC analysis.
Analysis of lung and lymph node DC phenotype after Pb
infection
The effects of Pb on surface molecule expression in lung DC
were investigated after intra-tracheal (i.t.) infection at 12 and 24 h.
Cells were isolated from lungs as previously described [14]. After
perfusing the pulmonary vasculature with 5 ml of PBS containing
100 U/ml heparin, the lungs were minced and incubated for
90 min at 37uC in digestion buffer containing 0.7 mg/ml
collagenase IV (Sigma-Aldrich- St. Louis-USA) and 30 mg/ml
type IV bovine pancreatic DNase I (Sigma-Aldrich- St. Louis-
USA). Large particulate matter was removed by passing the cell
suspension through a small loose nylon wool plug. The mediastinal
and axillary lymph nodes were removed and disrupted, and the
cells were analyzed. DC phenotype was determined by flow
cytometry using a FACSCantoII (Becton Dickinson). In order to
determine the expression of class II MHC co-stimulatory and
adhesion molecules, we used labeled Mabs against mouse PE-
CD11c (HL3) PECy5-CD11c (HL3), FITC-CD11c (HL3), PE-
MHC-II (M5-114.15.2), PE-CD80 (16-10A1), FITC-CD86 (GL1),
PE-CCR7 (4B12), APC-DC-SIGN (LWC06), and APC-CD103
(2E7) (All antibodies were obtained from BD Biosciences, San Jose,
CA). FlowJo was used for analysis of flow cytometry data. To
distinguish autofluorescent cells from cells expressing low levels of
individual surface markers, we established upper thresholds for
autofluorescence by staining samples with fluorescence-minus-one
(FMO) control stain sets [15]. In these sets, a reagent for a channel
of interest is omitted.
Bone marrow-derived DCs were generated according to
described methods [16]. Femurs and tibias were flushed with 3–
5 ml of PBS in 1% BSA. Bone marrow cells were differentiated
into DC by culturing in RPMI supplemented with 10% Fetal Calf
Serum (FCS), 10 mg/ml gentamicin, and recombinant cytokine
GM-CSF (50 ng/ml) for 7 days. On days 3 and 5, the
nonadherent cells (granulocytes and lymphocytes) were removed,
and the media was replaced with fresh media and growth factor.
On day 7, the nonadherent cells were removed and analyzed by
FACS using DC cell surface markers. The bone marrow-derived
DCs expressed MHC class II, CD80, CD40, CD11b and CD11c
(data not shown).
Analysis of in vivo DC migration
In order to analyze DC migration capability following Pb
interaction, we first used Bone-marrow derived dendritic cell (BM-
DC) marked with CFSE. BM-DCs were labeled for 20 min at
37uC with 5 mM carboxyfluorescein diacetate succinimidyl ester
(CFSE) (Molecular Probes, Eugene, OR). Following incubation,
labeling was stopped by the addition of RPMI/10% FBS, and the
cells were washed 3 times with RPMI at room temperature. To
reduce the amount of unbound CFSE in cell suspensions, the cells
were incubated at 37uC for 5 min after the second wash and prior
to the third wash. The CFSE-labeled DCs were incubated with Pb
(1:1) for 4 hrs and injected intratracheally (1610
5 DC in 50 ml
PBS). After 12 and 24 hrs, the mediastinal and axillary lymph
nodes were removed. Cells were isolated and analyzed by flow
cytometry as described above. As a control, we used CFSE-labeled
BM-DC without incubation with Pb.
CD4 T-cell activation after Pb-pulsed DC administration
To determine the type of T-cell activation occurring after
administration of Pb-pulsed DC, BM-DC (1610
5) were incubated
with Pb (1:1) for 4 hrs and injected intratracheally. After 5 days,
the mediastinal and axillary lymph nodes were removed and
disrupted, and the cells were analyzed. After surface staining for
CD4, the lymph node cells were fixed, permeabilized, and stained
by anti-IL-10, anti-IL-4 and anti-IFN-c Abs (BD). The cells were
analyzed by cytometry as described above.
CFSE labeling of migrating DC
To detect migrating lung DC, mice were lightly anesthetized
and intratracheally administered 1610
5 Pb diluted in PBS and
50 ml 8 mM CFSE (Fluka, Buchs, Switzerland) diluted in PBS.
This method is based on the labeling of intracellular proteins and
provides stable labels for at least 8 weeks in non-dividing
lymphocytes. This labeling procedure has frequently been used
to stain cells in the lungs and has allowed the tracking of
respiratory DC migration. After 12 and 24 hrs, the mediastinal
and axillary lymph nodes were removed. Cells were isolated and
analyzed by flow cytometry as described above. Mice administered
only CFSE were used as controls.
DC transport yeast form of Pb to draining lymph nodes
Labeling of yeast with FITC. Live yeast were suspended in
0.1 M carbonate buffer (pH 9.3) at 2610
8/ml and added to
200 ml of FITC in DMSO, as described [17]. After incubation for
2 h at room temperature while being protected from light, the
suspensions were diluted and washed twice in PBS (pH 7.2) to
remove all detectable free-FITC as determined by fluorescence
measurement of the supernatants when compared to PBS alone.
The yeast pellets were then counted and diluted in PBS to the
desired concentration. FITC labeling did not affect the viability of
cells. After labeling, 1610
6 Pb were injected intratracheally. After
12 h, the lymph node cells were removed and analyzed by
cytometry as described above. Animals injected with FITC only
were used as controls.
Statistics
Statistical comparisons were made by analysis of variance
(ANOVA) and by Tukey-Kramer test. All values were reported as
the mean +/2 standard error of the means.
Results
Pb infection alters the number and phenotype of lung
DCs
To study the role of Pb infection on lung DC, we infected
BALB/c mice intratracheally (i.t.) with the yeast form of Pb.A t1 2
and 24 hrs after infection, we analyzed the number and
phenotypes of lung DC by flow cytometry. We showed an
increased in the number of MHC-II
+/CD11c
+ cells (DC) after
P. brasiliensis-Induced Migration of DC
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19690Figure 1. Migration and phenotype of DC in lung during Pb infection. A- At several time points after Pb infection, the absolute numbers of
DC (MHC-II+/CD11c+) were determined in the lung. Error bars represent the SEM. B-Phenotype of lung DC after Pb infection, the gate represent
positive cells, determined by FMO, as described in the M&M. This figure is representative of 3 different experiments. The numbers represent the
percentage of positive cells. The experiment was performed at least 3 times. *p,0.05 when compared with PBS treatment.
doi:10.1371/journal.pone.0019690.g001
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19690Figure 2. Migration of BM-DC to the lymph nodes. BM-DC were incubated with Pb labeling with CFSE and injected into the lung. After 12 and
24 hrs the lymph nodes cells were analyzed by citometry. A-Figure representative of 3 different experiments, where the gate represent positive cells,
determined by FMO, as described in the M&M. The numbers represent the percentage of positive cells. B- At 12 and 24 hrs after Pb infection, the
absolute numbers of CFSE+/CD11c+ were determined in the lymph nodes. Error bars represent the SEM. *p,0.05 when compared with only DC.
doi:10.1371/journal.pone.0019690.g002
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e1969024 hrs of Pb infection (Figure 1A). In addition, an increase of DC
expression of CD103, MHC-II, and CCR7 when compared with
the controls (PBS) was observed (Figure 1B). No significant
differences were observed in the expression of CD80, CD86 and
DC-SIGN (data not shown).
In vivo DC Migration to the lung-draining lymph nodes.
Naı ¨ve T cell priming occurs in lymph nodes draining from the
site of infection. To study the capability of DC to migrate to the
lung-draining mediastinal lymph nodes, we labeled BM-DC with
CFSE, incubated with Pb and administered the solution
intratracheally to mice. Our results showed an increase of
CD11+/CFSE+ in the lymph nodes 12 hrs after administration
of fungus, but after 24 hrs the number decreased to control levels
(Figure 2B). Only CD11+CFSE+ cells incubated with Pb were
found in the lymph nodes (Figure 2A). These cells also expressed
mature phenotypic markers (MHC-II
high). These results demon-
strate that BM-DC, in the presence of Pb, migrate to draining
lymph nodes.
In addition, we analyzed the capacity of lung DC to migrate to
the lung-draining mediastinal lymph nodes. Mice were injected
(i.t.) with CFSE and Pb. This procedure enabled us to track DC
migrating from the lungs to the mediastinal lymph nodes during
Pb infection. In addition, flow cytometry allowed for the
separation of migrating DC and resident DC taken from the
lymph nodes. CFSE treatment alone did not induce significant
DC migration as demonstrated by the minimal number of CFSE-
labeled cells in the mediastinal lymph nodes after infection. After
intratracheal infection with Pb, the CFSE-labeled cells observed
in the mediastinal lymph nodes were predominantly CD11c cells
(Figure 3A). It was observed CFSE/CD11c+ cell at 12 hrs after
Pb infection, and after 24 hrs these cells decreased to control
levels (Figure 3B). These results show that lung DC have the
capability to migrate to the draining lymph nodes in the presence
of Pb.
DC transport yeast of Pb from the airways to the thoracic
lymph nodes
Recently, our group demonstrated that lung DC phagocytose Pb
yeast in vivo [18]. Moreover, in this study, we have shown that lung
DC migrate to the lymph nodes. Here, we address the question of
whether pulmonary DC, after phagocytosis of the fungus,
transport Pb yeast from the airways to the lymph nodes. To this
end, FITC-labeled yeast cells were i.t. injected, and the FITC-
positive DC were enumerated in lymph nodes by FACS analysis.
Our results showed that CD11c
+FITC
+ cells appeared in the
thoracic lymph nodes 12 hrs after infection. These results indicate
that pulmonary DC transport Pb yeast to the draining lymph nodes
(Figure 4).
Lymph node T-CD4 cell activation by DC
As demonstrated above, DC phagocytose the yeast form of Pb
and migrate to the lymph nodes. Given these results, DC were
considered likely to contribute to the induction of T cell responses.
Figure 3. Migration of lung DC to the lympho nodes. CFSE and Pb were injected into the lung and after 12 and 24 hrs the reginal lympho
nodes cells were analyzed to the presence of CFSE+/CD11c+ by citometry. A-Figure representative of 3 different experiments where the gate
represent positive cells, determined by FMO, as described in the M&M. The numbers represent the percentage of positive cells. B- At 12 and 24 hrs
after CFSE and Pb infection, the absolute numbers of CFSE+/CD11c+ were determined in the lympho nodes. Error bars represent the SEM. *p,0.05
when compared with only CFSE.
doi:10.1371/journal.pone.0019690.g003
Figure 4. DC transport yeast form of Pb to draining lymph nodes. Yeast form of Pb were labeling with FITC as described in the M&M. After
labeling, 1610
6 Pb were injected intratracheally. After 12 h, the lymph node cells were removed and analyzed by cytometry. Animals injected with
FITC only were used as controls. The Figure is representative of 3 different experiments. The number represent the percentage of positive cells.
doi:10.1371/journal.pone.0019690.g004
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DC, animals were injected with Pb or Pb-pulsed BM-DC, and
intracellular cytokines from T cells present in the lymph nodes
were investigated. Our results showed that animals infected with
Pb induced a mixed pattern of CD4 T cell cytokines, compatible
with a Th1/Th2 response. However, when Pb-pulsed DC was
injected, a Th2 response was observed in the draining lymph node
(Figure 5).
Discussion
PCM starts with inhalation of the fungus; thus, lung cells such
as DC are part of the first line of defense against this
microorganism. Migration of DC to the lymph nodes is the first
step in initiating T cell responses. DC are highly efficient antigen-
presenting cells that are central to the induction and regulation of
most adaptive immune responses. Their specialized capabilities of
acquiring, processing, retaining, and finally presenting peptides
on major histocompatibility complex (MHC) molecules are
critical properties that account in part for their major role in
antigen presentation [19]. Unlike other antigen-presenting cells,
DCs are specialized for homing efficiently to the T cell zones of
lymphoid organs, allowing for optimal interactions with T
lymphocytes. DC migratory capacity distinguishes them from
macrophages. Therefore, we postulated that DC, after interaction
with Pb, could migrate to the draining lymph nodes and activate
CD4 T-cells.
In this study, we showed that after Pb Infection, an important
modification of DC receptor expression occurred. We observed an
increased expression of CCR7 and CD103 on lung DC after
infection, as well as MHC-II. Several studies have shown that
pathogen recognition through PRRs activates DC leading to an
increase in DC expression of the chemokine receptors CCR7 and
CD103 [20][21] [11]. The increased expression enables DC to
migrate from the site of infection to the secondary lymphoid
tissues. Therefore, these results could indicate that DC are capable
of migration after interacting with Pb. Next, we infected mice with
Pb-pulsed BM-DC. Our results showed that DC pulsed with Pb
migrate to the lymph nodes. CFSE+ DC migrate to the lymph
nodes, therein coming into contact with naive T cells [11], and this
interaction results in the proliferation of naive T cells. Our results
showed that Pb-pulsed BM-DC induce a Th2-like response when
compared to infection with only Pb. These results demonstrate the
low capability of BM-DC to induce a Th1 response in the presence
of Pb. Recently, our group showed that BM-DC, in the presence of
Pb, decreased production of IL-12, a cytokine important for the
induction of Th1 [22].
However, it is known that BM-DC and lung DC have
differences in response, so it was necessary to test the in vivo
capacity of lung DC to migrate to lymph nodes following Pb
infection. Recently, we showedt h a tl u n gD Cc a np h a g o c y t o s e
the yeast form of Pb in vivo. The results of this study showed that
lung DC migrate and transport the yeast form of Pb to lymph
nodes. Migration of lung DC could represent an important
mechanism of pathogenesis during PCM infection. The lung
DC could act as Trojan horses for Pb and, depending on the
circumstances, influence disease susceptibility. However, this
hypothesis requires more study. In other model of fungal
infection it was demostrated that interactions between DC and
Crytococcus neoformans alter DC antigen-presenting functions and
modulate resultant T-cell responses in vitro [23]. Moreover, it
was shown that after cryptococcal infection in vivo, DC migrate
to thoracic lymph nodes and active T-cell to produce cytokine
[24][25]. Conversely, some pathogens are known to use
mechanisms to arrest DC migration to protect themselves from
the generation of potent adaptive immune responses. Schisto-
somal parasites produce prostaglandin D2 to inhibit DC
migration to lymph nodes after infection through skin [26],
and microbial antigens derived from Borrelia garinii,t h ec a u s a t i v e
agent of chronic Lyme disease, significantly downregulate CD38
and CCR7 expression in DC, thereby hampering their
migratory capability [27].
Figure 5. Lymph node T-CD4 cell activation by DC. Animals were
injected with Pb or Pb-pulsed BM-DC, and intracellular cytokines from T
cells present in the lymph nodes were investigated. The data represent
the mean 6 SEM of the results from 3 independent experiments. Error
bars represent the standard errors of the means (SEM). *p,0.05 when
compared between DC vs. DC+Pb infection or #p,0.05 when
compared between PBS vs. Pb infection.
doi:10.1371/journal.pone.0019690.g005
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19690Elucidating the mechanisms of regulation and coordination of
DC migration by pathogen-derived signals requires more study.
An understanding of the signals that regulate DC migration could
allow for the development of methods to induce efficient T-cell
activation that would aid in the control of PCM infection.
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